(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -160.31%-407.99K | 80.81%-716.86K | 48.15%-399.45K | 145.53%411.61K | 43.59%-572.28K | 85.02%-156.73K | -201.96%-3.74M | 42.91%-770.37K | -1,482.88%-904.08K | -239.47%-1.01M |
Net income from continuing operations | -186.75%-1.69M | 80.62%-1.21M | 80.48%-884.4K | 281.20%1.12M | -27.14%-852.04K | 55.59%-588.02K | 41.59%-6.23M | 46.37%-4.53M | 134.65%292.91K | 48.10%-670.15K |
Operating gains losses | 49,409.06%404.49K | -48.51%-1.92M | -10,506.07%-1.86M | ---- | ---- | -99.50%817 | -33.89%-1.29M | 104.18%17.87K | ---1.14M | ---332.16K |
Depreciation and amortization | 18.21%205.22K | -23.12%799.63K | 177.64%708.43K | -131.47%-82.41K | --0 | -33.57%173.61K | -28.53%1.04M | -35.43%255.16K | -25.94%261.88K | -25.99%261.7K |
Asset impairment expenditure | ---- | -80.59%596.8K | ---- | ---- | ---- | ---- | 30.91%3.08M | ---- | ---- | ---- |
Remuneration paid in stock | 151.57%307.12K | 75.49%472.51K | 345.24%472.51K | -211.73%-6.91K | -1,587.05%-115.18K | -25.46%122.08K | --269.25K | --106.12K | --6.18K | ---6.83K |
Other non cashItems | 161.51%67.03K | 579.32%1.07M | 4,412.26%958.58K | -623.70%-68.64K | 194.01%289.6K | -540.45%-108.97K | -96.58%157.59K | -99.53%21.24K | -44.54%13.11K | 47.06%98.5K |
Change In working capital | 20.75%294.33K | 29.70%-529.38K | -237.60%-391.6K | -45.10%-487.68K | 129.04%106.15K | 172.53%243.75K | -137.90%-753.05K | -2.80%284.6K | -181.79%-336.09K | -163.93%-365.48K |
-Change in receivables | 58.57%-58.48K | 183.90%664.85K | ---378.24K | --1.57M | -425.28%-384.49K | -332.75%-141.17K | -159.72%-792.46K | ---- | ---- | -142.46%-73.2K |
-Change in prepaid assets | 552.06%100.38K | -566.67%-150.7K | ---150.75K | --20.48K | -96.66%1.77K | 89.62%-22.21K | 198.86%32.29K | ---- | ---- | 4,201.78%53.08K |
-Change in payables and accrued expense | 26.21%-138.96K | 89.47%-18.23K | ---19.91K | --45.83K | 225.01%144.17K | 44.52%-188.32K | -122.26%-173.2K | ---- | ---- | -214.66%-115.32K |
-Change in other working capital | -34.27%391.39K | -668.61%-1.03M | --157.29K | ---2.12M | 249.84%344.69K | 280.30%595.44K | 310.75%180.32K | ---- | ---- | -176.66%-230.04K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -160.31%-407.99K | 80.81%-716.86K | 48.15%-399.45K | 145.53%411.6K | 43.59%-572.28K | 85.02%-156.73K | -201.96%-3.74M | 42.91%-770.37K | -1,482.88%-904.08K | -239.47%-1.01M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | 0 | 70.73%-256.45K | 99.45%-937 | 97.54%-5.23K | 55.33%-111.53K | |||
Capital expenditure reported | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -145.78%-111.53K |
Net PPE purchase and sale | ---- | --0 | --0 | --0 | ---- | ---- | -13.89%-17.08K | ---937 | -101.09%-5.23K | --0 |
Net intangibles purchas and sale | ---- | --0 | --0 | ---- | ---- | ---- | 72.21%-239.36K | --0 | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | --0 | --0 | --0 | ---- | ---- | 70.73%-256.45K | 99.45%-937 | 97.54%-5.23K | 55.33%-111.53K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -101.47%-13.29K | 43.15%972.28K | 21.76%997.24K | -108.54%-54.44K | -3,636.23%-874.61K | 219.97%904.1K | -88.28%679.19K | -80.83%819.04K | -24.37%637.15K | 91.07%-23.41K |
Net issuance payments of debt | -102.31%-20.56K | 44.62%954.02K | 19.53%978.97K | -105.66%-7.78K | -3,772.90%-906.61K | 425.31%889.43K | -54.72%659.65K | 73.37%819.03K | -88.48%137.44K | 94.85%-23.41K |
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---288 | --0 |
Proceeds from stock option exercised by employees | -50.48%7.26K | -6.48%18.27K | -6.48%18.27K | --0 | ---14.67K | --14.67K | --19.53K | --19.53K | --0 | --0 |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -101.47%-13.29K | 43.15%972.28K | 21.76%997.24K | -108.54%-54.44K | -3,636.23%-874.61K | 219.97%904.1K | -88.28%679.19K | -80.83%819.04K | -24.37%637.15K | 91.07%-23.41K |
Net cash flow | ||||||||||
Beginning cash position | 106.88%993.28K | -87.34%480.14K | -57.08%185.61K | -25.06%527.97K | -33.79%1.23M | -87.34%480.14K | 3,346.61%3.79M | -58.38%432.41K | 51.10%704.56K | 45.20%1.85M |
Current changes in cash | -156.37%-421.28K | 107.71%255.43K | 1,152.52%597.79K | 231.24%357.17K | -25.89%-1.45M | 138.55%747.37K | -189.95%-3.31M | -98.27%47.73K | -147.53%-272.16K | -41.81%-1.15M |
Effect of exchange rate changes | --14.7K | --257.72K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
End cash Position | -52.20%586.71K | 106.88%993.28K | 106.88%993.28K | -57.08%185.61K | -25.06%527.97K | -33.79%1.23M | -87.34%480.14K | -87.34%480.14K | -58.38%432.41K | 51.10%704.56K |
Free cash from | -160.31%-407.99K | 82.04%-716.86K | 48.21%-399.45K | 145.27%411.6K | 49.17%-572.28K | 86.77%-156.73K | -88.89%-3.99M | 49.24%-771.31K | -236.88%-909.31K | -105.28%-1.13M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.